Across TCGA pan-cancer cohorts, RPL23AP60 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL23AP60 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPL23AP60 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL23AP60 expression acts as an unfavorable survival marker.
UCEC, UVM, and BRCA are the cancer types where RPL23AP60 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.